Kidney Diseases

58 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Narrower: Acute Kidney Injury 3, Glomerulosclerosis, Focal Segmental 5, Kidney Calculi 1, Kidney Failure, Chronic 11, Nephrosis, Lipoid 3, Polycystic Kidney, Autosomal Dominant 1, Polycystic Kidney, Autosomal Recessive 1, Renal Insufficiency 44, Renal Insufficiency, Chronic 35, Uremia 1

Treatments and conditions

Kidney Diseases
Treatment and conditionWhere it standsTrials
10 GE Xenokidney for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Apecotrep for glomerulosclerosis, focal segmentalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Arm 2A: TRACT/MONO mTOR for kidney failure, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Arm 2B: TRACT/MONO CNI for kidney failure, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AZD7760 for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Belantamab mafodotin for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bepirovirsen for renal insufficiencyPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bladder Transplantation for renal insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Brivekimig for glomerulosclerosis, focal segmentalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brivekimig for nephrosis, lipoidPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cagrilintide for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ChoironeX GalKO Porcine Thymokidney for kidney failure, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cilastatin for acute kidney injuryPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cilastatin sodium for acute kidney injuryPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clazakizumab for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Combined Kidney and Bladder Transplantation for renal insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Concomitant Renal and Urinary Bladder Allograft Transplantation for renal insufficiency, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Droxidopa for acute kidney injuryPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Elasomeran for renal insufficiency, chronicTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for kidney failure, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Empagliflozin for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney + Kidney Transplantation with Standard Care for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Frexalimab for glomerulosclerosis, focal segmentalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Frexalimab for nephrosis, lipoidPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
GGTA1 KO Thymokidney for kidney failure, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HRS-1780 tablets for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
IGT-303 for renal insufficiency, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Intensified medical follow-up and glucose-lowering drugs for kidney diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN + GALLIUM GA-68 GOZETOTIDE for renal insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MSCs for renal insufficiency, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MT1013 for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
NightWare for renal insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Orforglipron for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Paxlovid for uremiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for glomerulosclerosis, focal segmentalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for kidney failure, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Rilzabrutinib for glomerulosclerosis, focal segmentalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Rilzabrutinib for nephrosis, lipoidPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Semaglutide + Cagrilintide for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sodium zirconium cyclosilicate for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
standard care + rotigotine at 4 mg/24h for 24 months. for kidney diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tenofovir Alafenamide Citrate for renal insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Testosterone for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor for renal insufficiency, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tolvaptan for polycystic kidney, autosomal recessivePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tozinameran for renal insufficiency, chronicTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
UKidney for kidney failure, chronicTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Upacicalcet for renal insufficiency, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Virtual Weight Management Coaching + Semaglutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
VX-407 for polycystic kidney, autosomal dominantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
YOLT-203 for kidney calculiPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zigakibart for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ziltivekimab for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.